Company · CIK 0001372299 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Ocugen, Inc. · OCGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 SForm 4 → | Sep 11, 9:13 pm EDT | Shankar MusunuriChief Executive Officer, Director | 525,991 | $1.12 | $589,110 | 1,088,035 | −32.6% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.